Method of Declaration. Hospitality/Interest/Sponsorship
|
|
|
- Miranda Williamson
- 5 years ago
- Views:
Transcription
1 Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 15/03/12 Sponsorship Abbott Laboratories Limited 12/03/13 Sponsorship Abbott Laboratories Limited 25/03/13 Sponsorship Abbvie Inc. 26/02/12 Hospitality AccuNostics Ltd 06/03/13 Interest AGFA Healthcare UK Ltd 21/03/12 Hospitality AGFA Healthcare UK Ltd 26/03/12 Hospitality AGFA Healthcare UK Ltd 26/03/12 Hospitality Alcon (Novartis) 24/04/12 Hospitality Allen & Hanburys Ltd 23/03/12 Sponsorship Allergan, Inc 17/04/12 Sponsorship Allergan, Inc 11/03/13 Sponsorship Alliance Healthcare 15/03/12 Hospitality Alliance Surgical PLC 17/04/12 Interest Almirall SA 17/04/12 Hospitality AlterG, Inc 22/02/12 Interest AlterG, Inc 22/02/12 Interest Amgen Ltd 22/03/12 Sponsorship Amgen Ltd 17/04/12 Interest Amgen Ltd 21/11/12 Interest Andreas Weiter 18/02/13 Hospitality AORFIX (Lombard Medical Technologies PLC ) 22/03/12 Sponsorship AORFIX (Lombard Medical Technologies PLC ) 22/03/12 Sponsorship ArthroCare Corporation 22/03/12 Sponsorship ArthroCare Corporation 15/04/13 Sponsorship Aspyra LLC 30/03/12 Interest Astellas Inc 30/11/12 Sponsorship Astellas Inc 30/11/12 Sponsorship Astellas Pharma Ltd 22/02/12 Interest Astellas Pharma Ltd 22/02/12 Sponsorship
2 Astellas Pharma Ltd 08/05/13 Hospitality Astellas Pharma Ltd 23/03/12 Sponsorship Astellas Pharma Ltd 17/04/12 Sponsorship Astellas Pharma Ltd 18/05/12 Hospitality Astellas Pharma Ltd 24/08/12 Interest Astellas Pharma Ltd 24/08/12 Interest Astellas Pharma Ltd 24/08/12 Interest Astellas Pharma Ltd 14/03/13 Sponsorship AstraZeneca UK Limited 08/05/12 Interest AstraZeneca UK Limited 17/04/12 Interest AstraZeneca UK Limited 24/10/12 Interest AstraZeneca UK Limited 08/05/12 Interest AstraZeneca UK Limited, GlaxoSmithKline plc, Chiesi Ltd 14/03/12 Interest AXA PPP Healthcare Limited 23/03/12 Interest B. Braun Medical Ltd 09/05/12 Interest Bard Limited 27/03/13 Sponsorship Bard Limited 27/03/13 Hospitality Bard Limited 27/03/12 Interest Bard Limited 27/03/13 Interest Baxter Healthcare Pharmaceutical Limited 17/04/12 Hospitality Bayer Healthcare AG 28/05/12 Interest Bayer Healthcare AG 18/02/13 Interest Bayer Healthcare AG 21/03/12 Sponsorship BCIA 30/03/12 Sponsorship Biomerieux UK Limited 22/02/12 Sponsorship Biomerieux UK Limited 22/03/12 Hospitality Biomerieux UK Limited 22/02/12 Sponsorship Biosense Medical Ltd 23/03/12 Sponsorship Biosense Medical Ltd 23/03/12 Hospitality Biosense Webster, Inc 27/03/13 Sponsorship Biosensors Europe SA 15/03/13 Sponsorship Biosensors International Group, Ltd. 28/05/12 Sponsorship Biosensors International Group, Ltd. 27/06/12 Interest Boehringer Ingelheim Limited and GE Healthcare 17/04/12 Sponsorship Boehringer Ingelheim Limited 13/03/12 Sponsorship Boehringer Ingelheim Limited 22/03/12 Sponsorship Boehringer Ingelheim Limited 23/03/12 Sponsorship Boehringer Ingelheim Limited 29/03/12 Sponsorship
3 Boehringer Ingelheim Limited 24/04/12 Sponsorship Boehringer Ingelheim Limited 08/03/13 Hospitality Boehringer Ingelheim Limited 20/03/13 Sponsorship Boehringer Ingelheim Limited and Sanofi UK 24/04/12 Interest Boehringer Ingelheim Ltd, Prostraken, Amgen Limited, Servier Laboratories Ltd 22/02/12 Sponsorship Boston Medical 06/05/13 Hospitality Boston Scientific 27/02/12 Interest Boston Scientific 22/03/12 Sponsorship Boston Scientific 22/03/12 Sponsorship Boston Scientific 23/03/12 Sponsorship Boston Scientific 18/05/12 Sponsorship Boston Scientific 27/06/12 Interest Boston Scientific 27/06/12 Sponsorship Boston Scientific 22/11/12 Interest Boston Scientific 15/02/13 Interest Boston Scientific 15/02/13 Interest Boston Scientific 18/02/13 Interest Boston Scientific 19/02/13 Sponsorship Boston Scientific 14/03/13 Sponsorship Bracco Imaging Spa 17/04/12 Sponsorship Bristol-Myers Squibb Pharmaceuticals Limited 27/06/12 Sponsorship Bristol-Myers Squibb Pharmaceuticals Limited 08/03/13 Sponsorship Cardiorenal Forum 27/02/12 Interest Carestream Health UK, Limited 08/05/13 Hospitality Carestream Health UK, Limited 08/05/13 Hospitality Carestream Health UK, Limited 14/03/13 Hospitality Carestream Health UK, Limited 06/05/13 Hospitality Carestream Health UK, Limited 19/03/13 Hospitality Celgene Limited 22/03/12 Sponsorship Celgene Limited 22/03/12 Sponsorship Celgene Limited 22/03/12 Sponsorship Celgene Limited 21/11/12 Sponsorship Celgene Limited 04/04/13 Sponsorship Celgene Limited, Janssen-Cilag Ltd and Chugai Pharma Europe Ltd 06/05/13 Hospitality CESP Dorset & New Forest LLP (Consultant Eye Surgeons Partnership) 08/05/13 Interest CESP Dorset & New Forest LLP (Consultant Eye Surgeons Partnership) 26/03/12 Interest CESP Dorset & New Forest LLP (Consultant Eye Surgeons Partnership) 28/03/12 Interest CESP Dorset & New Forest LLP (Consultant Eye Surgeons Partnership) 28/03/12 Interest
4 CESP Dorset & New Forest LLP (Consultant Eye Surgeons Partnership) and New Medica 16/07/12 Interest Chas A Blatchford & Sons Ltd 08/03/12 Sponsorship Chiesi Ltd 08/05/13 Interest Chugai Pharma Europe Ltd 22/03/12 Sponsorship Cook Medical Limited 17/04/12 Hospitality Cook Medical Limited 27/03/13 Interest Cook Medical Limited 06/05/13 Hospitality Cook Medical Limited 21/03/12 Sponsorship Cook Medical Limited 22/03/12 Sponsorship Cook Medical Limited 23/03/12 Sponsorship Cook Medical Limited 23/03/12 Sponsorship Cook Medical Limited 28/05/12 Sponsorship Cook Medical Limited 22/08/12 Sponsorship Cook Medical Limited 10/04/13 Sponsorship Cook Medical Limited 10/04/13 Sponsorship Cordis Corporation 29/03/12 Sponsorship Corin Group PLC 22/03/12 Interest Covidien plc 10/04/13 Sponsorship Covidien plc 29/03/12 Hospitality Covidien plc 29/03/12 Sponsorship Daicchi Sankyo UK Ltd, Merck Sharp & Dohme Limited, Reckitt Benckiser Healthcare (UK) Limited 08/03/12 Sponsorship Davol Inc (C R Bard Inc) 27/03/12 Interest DePuy Companies and ArthroCare Corporation 22/03/12 Sponsorship DePuy Companies 22/03/12 Sponsorship DePuy Companies 17/04/12 Hospitality DePuy Companies 15/04/13 Sponsorship DePuy Companies 15/04/13 Sponsorship DePuy Companies 22/04/13 Interest
5 Dr Falk Pharma UK Ltd 13/01/12 Sponsorship Dr Falk Pharma UK Ltd 23/03/12 Hospitality Dr Falk Pharma UK Ltd 23/03/12 Hospitality Dr Falk Pharma UK Ltd 23/03/12 Hospitality Dr Falk Pharma UK Ltd 23/03/12 Interest Dr Falk Pharma UK Ltd 30/03/12 Sponsorship Dr Falk Pharma UK Ltd 22/02/12 Interest Dr Falk Pharma UK Ltd 26/02/13 Hospitality Dr Falk Pharma UK Ltd 04/03/13 Sponsorship Dr Falk Pharma UK Ltd 10/10/12 Sponsorship Drägerwerk AG &Co.KGaA 17/04/12 Sponsorship Eli Lilly & Co Ltd 06/05/13 Hospitality Eli Lilly & Co Ltd and Merck Sharp & Dohme Limited 26/03/12 Interest Eli Lilly & Co Ltd, GlaxoSmithKline plc, Astellas Pharma Ltd 17/04/12 Interest Endologix International B.V. 22/02/12 Interest Endologix International B.V. 01/03/12 Hospitality Endologix International B.V. 21/03/12 Sponsorship Endologix International B.V. 23/03/12 Sponsorship Endologix International B.V. 23/03/12 Sponsorship Endologix International B.V. 23/03/12 Sponsorship Endologix International B.V. 23/03/12 Sponsorship Endologix International B.V. 17/04/12 Interest Endologix International B.V. 17/04/12 Hospitality Ethicon (Johnson & Johnson Medical Limited) 06/03/13 Interest Ethicon (Johnson & Johnson Medical Limited) 30/11/12 Sponsorship Ethicon (Johnson & Johnson Medical Limited) 17/04/12 Sponsorship Ferring Pharmaceuticals Limited 13/01/12 Sponsorship Firstkind Limited 02/04/13 Interest Gedeon Richter Plc 08/03/12 Interest
6 Gilead Sciences Ltd 02/05/12 Sponsorship Gilead Sciences Ltd 09/07/12 Sponsorship Gilead Sciences Ltd, Janssen-Cilag Ltd, Schering-Plough Limited 26/03/12 Hospitality Gilead Sciences Ltd, Janssen-Cilag Ltd, Schering-Plough Limited 26/03/12 Hospitality GlaxoSmithKline plc 22/02/12 Interest GlaxoSmithKline plc 22/03/12 Interest GlaxoSmithKline plc 20/09/12 Sponsorship Grünenthal Ltd. UK 22/03/12 Sponsorship Guerbet Laboratories Ltd 22/03/12 Sponsorship Hitachi Medical Systems UK Limited 08/05/13 Interest Hitachi Medical Systems UK Limited 08/05/13 Interest Hitachi Medical Systems UK Limited 14/03/12 Hospitality Hitachi Medical Systems UK Limited Hitachi Medical Systems UK Limited and Cook Medical Limited 23/03/12 Hospitality Hitachi Medical Systems UK Limited and Pentax U.K. Limited 30/03/12 Sponsorship Hollister Limited 19/10/12 Sponsorship Immunotec Ltd 30/03/12 Interest Implantable Devices Course 27/02/12 Interest Ipsen Limited 07/03/12 Sponsorship Janssen-Cilag Ltd 23/03/12 Sponsorship Janssen-Cilag Ltd 18/02/13 Sponsorship Janssen-Cilag Ltd 23/03/12 Sponsorship Janssen-Cilag Ltd 14/03/12 Sponsorship Johnson & Johnson Medical Ltd 15/03/12 Hospitality JRI Orthopaedics Limited 07/05/13 Sponsorship KCI Europe Holding BV 24/04/12 Interest KCI Europe Holding BV 27/06/12 Hospitality Kier Group plc 17/04/12 Hospitality Labxcell Limited 08/05/13 Interest Labxcell Limited 21/03/12 Interest LeMaitre Vascular GmbH /Endologix International B.V. 17/04/12 Sponsorship LifeCell Corporation (KCI Europe Holding BV) 23/02/12 Interest LifeCell Corporation (KCI Europe Holding BV) 08/03/12 Interest Link 19/03/12 Sponsorship Lombard Medical Technologies PLC 27/02/12 Sponsorship Lombard Medical Technologies PLC 27/02/12 Sponsorship Lombard Medical Technologies PLC 17/04/12 Hospitality Lombard Medical Technologies PLC 17/04/12 Hospitality
7 Lombard Medical Technologies PLC 27/02/12 Interest Lombard Medical Technologies PLC 23/03/12 Sponsorship Lundbeck Limited 07/05/13 Sponsorship Lundbeck Limited 22/03/12 Sponsorship Lundbeck Limited 22/03/12 Sponsorship Marsh Ltd 30/04/12 Hospitality MDS Foundation 22/03/12 Sponsorship Medi8 Events Solutions 27/06/12 Sponsorship Medicology Ltd 08/03/12 Sponsorship Medtronic Limited 27/02/13 Interest Medtronic Limited 27/02/13 Interest Medtronic Limited 27/03/12 Sponsorship Medtronic Limited 27/02/12 Interest Medtronic Limited 23/03/12 Sponsorship Medtronic Limited 23/03/12 Hospitality Medtronic Limited 23/03/12 Hospitality Medtronic Limited 27/06/12 Sponsorship Medtronic Limited 15/02/13 Interest Menarini Pharmaceuticals 17/04/12 Interest Merck Sharp & Dohme Limited 13/01/12 Interest Merck Sharp & Dohme Limited 06/05/12 Hospitality Merck Sharp & Dohme Limited 23/03/12 Other Merck Sharp & Dohme Limited 27/06/12 Sponsorship Merck Sharp & Dohme Limited 19/10/12 Sponsorship Merck Sharp & Dohme Limited 18/02/13 Interest Merz Pharma UK Ltd 17/04/12 Sponsorship Moximed Inc 22/04/13 Hospitality Neomedic Internacional 18/02/13 Sponsorship Newmedica 28/03/12 Interest Newmedica 28/03/12 Interest Newmedica 24/04/12 Interest Newmedica 30/04/12 Interest Novartis Pharmaceuticals UK Limited 06/05/13 Other Novartis Pharmaceuticals UK Limited 23/03/12 Interest Novartis Pharmaceuticals UK Limited 26/03/12 Sponsorship Novartis Pharmaceuticals UK Limited 17/04/12 Sponsorship Novartis Pharmaceuticals UK Limited 09/07/12 Sponsorship Novartis Pharmaceuticals UK Limited 17/12/12 Sponsorship Novartis Pharmaceuticals UK Limited 04/04/13 Sponsorship
8 Novo Nordisk Ltd 23/03/12 Other Novo Nordisk Ltd 23/03/12 Other Novo Nordisk Ltd 23/03/12 Other Nutricia Ltd 29/03/12 Sponsorship Oncura (GE Healthcare) 26/03/12 Sponsorship Pfizer Ltd 28/05/12 Interest Pfizer Ltd 22/03/12 Sponsorship Pfizer Ltd 17/04/12 Interest Pfizer Ltd 17/04/12 Interest Pfizer Ltd 27/06/12 Sponsorship Pfizer Ltd 24/08/12 Interest Pfizer Ltd 19/10/12 Sponsorship Pfizer Ltd 14/03/13 Hospitality Pfizer Ltd 22/04/13 Sponsorship Pfizer Ltd 22/04/13 Sponsorship Pfizer Ltd and Philips Healthcare 08/03/12 Sponsorship Philips Healthcare 17/04/12 Hospitality Profile Productions Ltd 08/05/13 Sponsorship QIAGEN Ltd. 19/03/13 Sponsorship Roche Diagnostics Limited 06/05/13 Interest Roche Diagnostics Limited 23/03/12 Interest Roche Diagnostics Limited 23/03/12 Interest Roche Products Limited 29/03/12 Sponsorship Roche Products Limited 30/03/12 Interest Roche Products Limited 27/06/12 Hospitality Roche Products Limited 08/05/13 Sponsorship Roche Products Limited 19/03/12 Sponsorship Roche Products Limited 22/03/12 Sponsorship Roche Products Limited 22/03/12 Sponsorship Roche Products Limited 26/03/12 Sponsorship Roche Products Limited 18/02/13 Interest Roche Products Limited 23/03/12 Interest Roche Products Limited 23/03/12 Interest Roche Products Limited 19/10/12 Interest Roche Products Limited 19/03/13 Hospitality Rochester Medical Limited 19/10/12 Sponsorship Sanofi UK 23/03/12 Sponsorship Shine Potential 21/03/12 Interest Shire Pharmaceuticals Ltd 22/03/12 Sponsorship
9 Shire Pharmaceuticals Ltd 23/03/12 Sponsorship Shire Pharmaceuticals Ltd 17/04/12 Interest Shire Pharmaceuticals Ltd Sponsorship Siemens 14/03/13 Hospitality Siemens 08/05/13 Hospitality Siemens 08/05/13 Sponsorship Siemens 19/03/13 Hospitality Siemens 08/05/13 Hospitality Sigmacon Limited 17/04/12 Sponsorship SMA Nutrition 17/04/12 Interest Smith & Nephew UK Limited 19/03/12 Interest Smith & Nephew UK Limited 19/03/12 Sponsorship Smith & Nephew UK Limited 22/03/12 Sponsorship Smith & Nephew UK Limited 26/02/13 Sponsorship Smith & Nephew UK Limited 23/01/12 Sponsorship Smith & Nephew UK Limited 23/01/12 Sponsorship Smiths Medical International Ltd 02/05/13 Sponsorship Speciality European Pharma Limited 17/04/12 Sponsorship Spectranetics 12/03/13 Hospitality St. Jude Medical UK Ltd. 23/03/12 Sponsorship St. Jude Medical UK Ltd. 23/03/12 Sponsorship St. Jude Medical UK Ltd. 23/03/12 Hospitality St. Jude Medical UK Ltd. 17/04/12 Sponsorship St. Jude Medical UK Ltd. 30/07/12 Interest St. Jude Medical UK Ltd. 15/02/13 Interest St. Jude Medical UK Ltd. 15/02/13 Interest St. Jude Medical UK Ltd., Boston Scientific, Medtronic Limited 29/03/12 Sponsorship STORTL 09/07/12 Interest Stryker Corporation 24/04/12 Hospitality SynMed Ltd 23/03/12 Sponsorship SynMed Ltd 23/03/12 Sponsorship Takeda UK Ltd 17/04/12 Sponsorship Talley Group Limited 15/03/13 Sponsorship Technomed Ltd 08/05/13 Interest TECNA 27/11/12 Interest Terumo UK Ltd 21/03/12 Sponsorship Terumo UK Ltd 22/03/12 Sponsorship Terumo UK Ltd 23/03/12 Interest Teva UK Limited 22/10/12 Sponsorship
10 Toshiba Medical Systems Ltd 22/03/12 Hospitality Toshiba Medical Systems Ltd 22/03/12 Hospitality Toshiba Medical Systems Ltd 22/03/12 Sponsorship Toshiba Medical Systems Ltd 26/03/12 Hospitality Toshiba Medical Systems Ltd 28/03/12 Sponsorship Toshiba Medical Systems Ltd 25/03/13 Sponsorship Toshiba Medical Systems Ltd 08/05/13 Hospitality Toshiba Medical Systems Ltd 08/05/13 Hospitality Toshiba Medical Systems Ltd 15/03/14 Hospitality Toshiba Medical Systems Ltd 07/05/13 Hospitality Toshiba Medical Systems Ltd 08/05/13 Sponsorship Toshiba Medical Systems Ltd 19/03/13 Hospitality UCB Pharma Ltd 11/07/12 Interest UCB Pharma Ltd 29/03/12 Sponsorship UCB Pharma SA 27/07/12 Sponsorship United Kingdom National External Quality Assessment Service 21/03/12 Interest Vital Images UK 08/05/12 Sponsorship Vitatron Ltd (Medtronic Inc) 28/05/12 Interest W.L. Gore and Associates (U.K.) Limited 22/03/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 23/03/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 17/04/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 17/04/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 27/02/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 03/12/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 27/02/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 17/04/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 20/07/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 20/07/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 23/09/12 Sponsorship W.L. Gore and Associates (U.K.) Limited 08/03/13 Sponsorship W.L. Gore and Associates (U.K.) Limited Hospitality W.L. Gore and Associates (U.K.) Limited and Lombard Medical Technologies PLC 17/04/12 Sponsorship WG Healthcare UK Ltd 22/03/12 Hospitality Zimmer, Ltd. 15/04/13 Sponsorship The Zimmer Institute 18/02/13 Sponsorship Zimmer, Ltd. 30/04/12 Sponsorship Zimmer, Ltd. 29/11/12 Sponsorship Zimmer, Ltd. 29/11/12` Sponsorship
11 Zimmer, Ltd. 19/03/12 Interest Zimmer, Ltd. 19/03/12 Sponsorship Zimmer, Ltd. 22/03/13 Interest Zimmer, Ltd. 17/04/12 Sponsorship Zimmer, Ltd. 24/04/12 Sponsorship Zimmer, Ltd. 30/04/12 Sponsorship Zimmer, Ltd. 30/04/12 Sponsorship
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable
Corporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None
AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara,
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
European companies outpace American counterparts in R&D investment growth for the first time in five years
IP/08/1504 Brussels, 15 October 2008 European companies outpace American counterparts in R&D investment growth for the first time in five years R&D investment by EU companies has increased by 8.8% compared
The 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
Previous Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
TRENDS IN IP DISPUTES
ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating
Early Valuation. Company Portfolio
Early Valuation Company Portfolio The current strategy Idea PoC Regulatory Clinical Development Basic Science / Experts Operations Marketing / KOL Commercial Health Innovation Technology Transfer 1 I d
The 2010 EU industrial R&D investment SCOREBOARD
1 The 2010 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández 2 Contents 1. Background 2. Overall R&D trends 3. Top R&D companies 4. R&D by region 5. R&D
Institutional, Organizational, or Other Financial. Ownership/ Partnership/Principa. Speakers Bureau. Reviewer Representation Employment Consultant
Relationships With Industry and Other Entities (Comprehensive) 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (August 2018) Institutional,,
HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging
Author Listing of Comprehensive Relationships With Industry and Other Entities for the ACCF/AHA/ASE/ASNC/HRS/IAC/MENDED HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of
2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions
2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions FRIDAY, 4 MAY 8:30 AM 3 PM New York Genome Center 101 Avenue of the Americas New York, NY 10013 HBAnet.org Event
TODAY LETTER DATED
TODAY LETTER DATED 05.07.2018 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF LETTER 1. M/S. CLIANTHA RESEARCH LTD., AHMEDABAD-380054 23483 CLARIFICATION LETTER 2. M/S. EMCURE LIMITED, PUNE-
Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
2017 IPCC Attendee List
2017 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2017 Company Abbvie Inc. AbbVie Inc. AbbVie Inc. AgTech Accelerator AIPLA Akebia Therapeutics, Inc Alkermes, Inc. Alkermes, Inc.
Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics
Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics Conference Co-Chairs Dr. Richard Popp Acumen Medical Pelikan Technologies Percardia, Inc. Acumen Medical Agilent
Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
ACC.13 Committee Disclosures Page 1 of 9
ACC.13 Program Committee Disclosures Last First Direcr Grants Alexander Karen P. Gilead Sanofi Aventis Ananthasu Karthikeya Lantheus Imaging bramaniam n Lantheus Imaging, Astellas Pharma US, Inc Astellas
HESI Annual Meeting January 19, Welcome!!!! Meeting of the. HESI Assembly of Members. Dr. James MacDonald President of HESI 01/19/09
HESI Annual Meeting January 19, 2009 Welcome!!!! Meeting of the HESI Assembly of Members Dr. James MacDonald President of HESI The HESI logo... Depicts our commitment to the tripartite approach... Government!
ACC.17 Program Committee Disclosures of Relationships With Industry Disclosures
ACC.17 Program Committee of Relationships With Industry Name Brian G. Abbott, MD, J. Dawn Abbott, MD, DATA SAFETY MONITORING BOARD - Pfizer Nazem Akoum, MD, CONSULTANT FEES/HONORARIA - Biotronik Karen
2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA
Learner Notification 2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA Acknowledgement of Financial Commercial Support No financial commercial support was received for this educational activity.
The importance of transnational corporations in research and development activities in the world
Jagiellonian Journal of Management vol. 3 (2017), no. 2, pp. 65 75 doi:10.4467/2450114xjjm.17.005.7735 www.ejournals.eu/jjm The importance of transnational corporations in research and development activities
SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.
SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision
Monetizing Early-Stage R&D Assets. March 18, 2015
Monetizing Early-Stage R&D Assets March 18, 2015 Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst
vision without limits BIOTECH CANTY PROCESS TECHNOLOGY BUFFALO DUBLIN THAILAND
vision without limits BIOTECH CANTY PROCESS TECHNOLOGY BUFFALO DUBLIN THAILAND Large, reflection-free lighting with rugged fiber optics Sanitary LED Lighting APPLICATIONS Biotech Applications Fermentors
World Preview 2013, Outlook to 2018 The Future of Medtech
World Preview 2013, Outlook to 2018 The Future of Medtech September 2013 Welcome to the EvaluateMedTech World Preview 2013, Outlook to 2018 Launched in October 2012, the EvaluateMedTech service is focused
Peter Forman President & CEO South Shore Chamber of Commerce
June 28, 2018 Peter Forman President & CEO South Shore Chamber of Commerce George Toma Chairman South Shore Chamber of Commerce Jim McDonough President & CEO Envision Bank Elliot F. Eisenberg, Ph.D. President:
COMPANY JOB TITLE COUNTRY
COMPANY JOB TITLE COUNTRY 4 Tech Cardio Research & Development Ireland 4Tech Cardio Research & Development Ireland 4Tech Cardio Production/Manufacturing Ireland 4Tech Cardio Production/Manufacturing Ireland
SPONSORSHIP 2009 guide
SPONSORSHIP 2009guide Prix Galien USA Committee The Prix Galien Award recognizes outstanding achievements in improving the global human condition through the development of innovative therapies. The Prix
LIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
IPCAA. Regulatory awareness still needs improving. INTERNATIONAL PHARMACEUTICAL CONGRESS ADVISORY ASSOCIATION No. 35 July 2010
IPCAA NEWS Regulatory awareness still needs improving Following continuing efforts to promote awareness of pharmaceutical industry codes and regulatory constraints on sponsors for medical congresses, it
Patent Documentation Group
Patent Documentation Group 1957-2008 Minoo Philipp President Patent Documentation Group http://www.p-d-g.org Patents are a very important source of technical information Need for abstracts of patent information
European Patent Reform Forum USA December , New York
European Patent Reform Forum USA December 8 2015, New York Delegate List Job Title Organisation SVP/ Senior IP Law ACell ADP Law Vice President Director Senior Manager, Licensing, IP Law Global, Diabetes
CAN Company Name M Company A A A A O N Corporation A T & T Corp Abbvie Corp Accenture Ltd.
CAN Company Name 005004 3 M Company 005010 A A A 007372 A O N Corporation 005207 A T & T Corp 020609 Abbvie Corp. 017610 Accenture Ltd. 008785 Adidas Corp 017083 Advanced Micro Devices 020742 Aflac - Corp.
VALUE IN HEALTH 20 (2017) A384 A397
A384 VALUE IN HEALTH 20 (2017) A384 A397 DISCLOSURE INFORMATION Research Presentations Financial Disclosure Statements The International Society for Pharmacoeconomics and Outcomes Research asked all abstract
Healthcare and Life Sciences Group. Mergers & Acquisitions
Healthcare and Life Sciences Group Mergers & Acquisitions Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
ACC.18 ABSTRACT REVIEWERS Disclosures
Name A. Michael Lincoff, M.D., FACC RESEARCH/RESEARCH GRANTS - AbbVie, Inc., Amgen, Astra Zeneca, Cerenis, CSL Behring, Edwards Lifesciences, Esperion, Ethicon, Infraredx, Janssen, Johnson & Johnson, Lilly,
NEW JERSEY INDUSTRY SPOTLIGHT LIFE SCIENCES CUSHMAN & WAKEFIELD RESEARCH
NEW JERSEY INDUSTRY SPOTLIGHT LIFE SCIENCES CUSHMAN & WAKEFIELD RESEARCH TABLE OF CONTENTS Cushman & Wakefield 2 3 KEY TAKEAWAYS 4 ECONOMIC IMPACT 5 R&D / FLEX MARKET 6 CLASS A OFFICE MARKET 7 LIFE SCIENCES
SPORTS MEDICINE: TECHNOLOGIES AND GLOBAL MARKETS
SPORTS MEDICINE: TECHNOLOGIES AND GLOBAL MARKETS HLC183A March 2015 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-061-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
The rise of Corporate Venture Capital investment in UK biotech
The rise of Corporate Venture Capital investment in UK biotech The rise of Corporate Venture Capital investment in UK biotech 1 Contents 2 Forewords 3 2.1 Corporate Venture Capital the patient capital
State of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile
Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business and market research
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
This report is prepared by:
Access to Medicine Index 2010 Access to Medicine Foundation The Access to Medicine Foundation is an international not for profit organization dedicated to improving access to medicines to societies in
VALUE IN HEALTH 18 (2015) A308-A318
A308 DISCLOSURE INFORMATION Research Presentations Financial Disclosure Statements The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose fi nancial
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
Europa Hotel Belfast. Exhibition & Educational Support Opportunities. 6th - 8th November. Annual Scientific Meeting 6th - 8th November 2013
Europa Hotel Belfast Exhibition & Educational Support Opportunities 6th - 8th November 2013 The annual BOFAS meeting is the premier foot & ankle forum in the UK BELFAST BOFAS welcome old friends from Industry
MARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013
MARKUSH FOR PATENT ANALYSIS Steve Hajkowski ChemAxon UGM Budapest 2013 THOMSON REUTERS MARKUSH DATA Indexing for 2.4 million patent families 1.6m Markush structures, re-drawn & stored in Thomson Reuters
Acknowledgements. Legal Notice
1 Acknowledgements The 2011 EU Industrial R&D Investment Scoreboard (Draft) has been published within the context of the Industrial Research Monitoring and Analysis (IRMA) activities that are jointly carried
MTaI MedTech Summit 2017 Demystifying the MedTech Sector September 15, 2017; Ball Room, Shangri-La's - Eros Hotel, Ashoka Road, New Delhi
MTaI MedTech Summit 2017 Demystifying the MedTech Sector September 15, 2017; Ball Room, Shangri-La's - Eros Hotel, Ashoka Road, New Delhi DRAFT PROGRAMME (AS ON SEPTEMBER 13, 2017) 0830-0930 Hrs Registration
Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness
2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities
Skystar Bio-Pharmaceutical Co SKBI
Morningstar Analyst Rating Page 1 of 6 Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 0.01 [0.00 0.00 % $ 0.01 0.01-0.01 0.00-0.20
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions
Disclosure Statements
Disclosure Statements This index contains financial disclosure statements for RSNA 2018 faculty who have or have had an affiliation or financial relationship with any commercial interest within the previous
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
Empirical Investigation of the Blog space: the Case of European Pharmaceuticals KGCM 2008
Empirical Investigation of the Blog space: the Case of European Pharmaceuticals KGCM 2008 Emanuela TODEVA Faculty of Management & Law, University of Surrey, UK and Donka KESKINOVA Department of Sociology,
ROCHE DIAGNOSTICS LTD IMPERIAL COLLEGE HEALTHCARE NHS TRUST LIAISON FINANCIAL SERVICES K C HOLIDAY DIALYSIS CENTRE NOVARTIS PHARMACEUTICALS UK LTD
Customer/Supplier description NATIONAL LOANS FUND NHS SUPPLY CHAIN FRESENIUS MEDICAL CARE RENAL SERVICES LTD ROCHE PRODUCTS LTD EDF ENERGY 1 LTD NHS SUPPLY CHAIN NHS SUPPLY CHAIN NHS SUPPLY CHAIN CELERITY
Country Organisation. CADTH; DSEN, Canadian Institutes of Health Research, INESSS, Alberta Health Services. Danish Health and Medicines Authority
MISSION To maintain a leadership role in identifying and applying scientific principles for the purpose of advancing regulatory and HTA policies and processes in developing and facilitating access to medicinal
Skystar Bio-Pharmaceutical Co SKBI
Morningstar Analyst Rating Page 1 of 6 Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 0.00 [0.00 0.00 % $ 0.00 0.00-0.00 0.00-0.10
2018 IPCC Attendee List
2018 IPCC Attendee List Includes attendees from both IPCC Spring and Fall 2018 Title Head of Intellectual Property Vice President IP Asst. Program Officer Health Supervisor Public Health Asst. Health Youth
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through
Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,
Heart Valve Summit: Medical, Surgical and Interventional Decision Making
Disclosure/Conflict of Interest Statement As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American
B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems
B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems May 18 th, 2017 Location: Gasometer, EUREF-Campus 17, 10829 Berlin Conference Agenda (as of
Reference List Cha, Myoung., and Theresa Lorriman. February Why Pharma megamergers work. McKinsey&Company Our insights. Ward, Andrew.
Reference List Cha, Myoung., and Theresa Lorriman. February 2014. Why Pharma megamergers work. McKinsey&Company Our insights. Ward, Andrew. September 24, 2015. Pharmaceuticals: Value over Volume. Financial
National Association for Female Executives Top 50 Companies. Executive Summary 2010
National Association for Female Executives Top 50 Companies Executive Summary 2010 CEO Representation Seven of the NAFE Top Companies have Women CEOs, compared to fifteen of the Fortune 500 Companies NAFE
We Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations
We Work For Health Champions Awards Class of 2012 Brief Biographical Information (Alphabetical by Member Company) The We Work For Health Champion Awards are given annually to those to individuals who have
Medical Device Breakout Session
Medical Device Breakout Session Brian Horne, Sabing Lee and Gerard von Hoffmann November 6, 2014 IP Impact 2014 Overview Medical device patent statistics Non-practicing entity (NPE) litigation Inter partes
The Netherlands Life Sciences Gateway to Europe
The Netherlands Life Sciences Gateway to Europe WHY FOREIGN LIFE SCIENCE COMPANIES INVEST IN THE NETHERLANDS Centrally located between Germany, France and the UK with a highly efficient (logistics) infrastructure
Innovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
Born Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.
Board of Directors Håkan Björklund Chairman Born 1956. Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016. Other appointments: Currently serves as Industry Executive at Avista Capital
MATCHING GIFT COMPANY LIST
MATCHING GIFT COMPANY LIST This is a list of corporations that have matched donations to events benefiting Susan G. Komen for the Cure in the past. Please review your corporation s matching gift guidelines
TENTATIVE BID DATE. ENDOSCOPY May-11 Dawn Janicki Caths/Stents/Inst. $ 66,833
BID CALENDAR - JHHS Volumes indicated below represent Johns Hopkins Health System excluding Howard, Sibley, Suburban - These entities may join volumes prior to the bid occurrence COMMODITY/ PRODUCTS TENTATIVE
Industry's Expectation on Classification. Bernd Wolter (Siemens AG, Munich)
Industry's Expectation on Classification Bernd Wolter (Siemens AG, Munich) Who are the PDG? Founded in 1957 The objective is to facilitate and promote the efficient and effective use of patent information
MEMBER COMPANIES AND PARTICIPATING AUTHORITIES
MISSION To maintain a leadership role in identifying and applying scientific principles for the purpose of advancing regulatory and HTA policies and processes in developing and facilitating access to medicinal
Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF
Page 1 of 6 Morningstar Analyst Rating. Last Price Day Change Open Price Day Range 52-Week Range Proj. Yield Market Cap Volume Avg Vol. Forward P/E P/B P/S P/CF $ 86.57 ]1.05 1.23 % $ 86.09 85.93-86.75
1. Your Identity. Photo. Treasurer. Application for the following position in the EHRA Board: Title: Prof, MD. Family Name(s): Pürerfellner
Photo Application for the following position in the EHRA Board: Treasurer 1. Your Identity Title: Prof, MD Family Name(s): Pürerfellner First Name(s): Helmut Friedrich Birth Date: 02-Apr-1961 Type of address:
Professional Milling and Handling of Powders
HammerWitt-Lab The new hammer mill for small batch production and laboratory application with upgraded process characteristics for the pharmaceutical, food, and fine chemical industries. Professional Milling
Officer Director etc. Ownership Partnership Principal. Speaker's Bureau
ACC.14 and TCT@ACC-i2 Program Committees' Disclosures of Relationships with Industry Moniring Last Abbott J. Dawn YES YES Pfizer Bosn scientific Adams David H. YES YES Medtronic, Edwards Lifesciences,
Committee Disclosures Page 1 of 12
TCT@ACC-i2 Program Committee Disclosures Last Name First Name Middle Name Nothing to Grants Abbott J. Dawn X Abizaid Alexandre Abbott, Boston Scientific Angiolillo Dominick J. Eli Lilly, Daiichi-Sankyo,
Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health
Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health March 8, 2012 Boston Geneva Mumbai San Francisco Seattle Washington Contents 1. Plenary Session
Author Disclosures. Inc
Author Disclosures A Abbara, S.-Consultant, Perceptive Informatics, ; Author with royalties, Reed Elsevier; Author with royalties, Amirsys, Abbott, G. F.-Author, Thieme Medical Publishers, ; Author, Amirsys,
NOTICE OF ANNUAL GENERAL MEETING. Thursday 30 March 2017 at am. H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby
TO THE SHAREHOLDERS OF H. LUNDBECK A/S NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Thursday 30 March 2017 at 10.00 am The general
2017 Post Show Report
The exhibition dedicated to medical device design 2017 Post Show Report 2017.09.20-22 Hall 2 of Shanghai World Expo Exhibition & Convention Center Organizer Exclusive Co-organizer Honorable Supporting
PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update
PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease